# Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

> **NCT01669512** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 23 (actual)

## Conditions studied

- Malaria
- Matrix M

## Interventions

- **BIOLOGICAL:** Control Regimen
- **BIOLOGICAL:** Low Dose Matrix M Regimen
- **BIOLOGICAL:** Standard Dose Matrix M Regimen

## Key facts

- **NCT ID:** NCT01669512
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669512, "Adjuvanting Viral Vectored Malaria Vaccines With Matrix M". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01669512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*